0      0

When Size Matters: A Broadly Neutralizing Single Domain Antibody to Prevent and Treat COVID 19

‐ Jan 13, 2021 10:55am


You must be logged in and own this session in order to post comments.

Leo OzurumbaDwight
1/13/21 11:46 am

Good day sir. This is now an emerging trend in search for Sarscov-2 Ab drugs- ensuring it's capacity for cross neutralization across emerging strains. Then, not loosing sight of qualities for long lasting protection. Testing mAb with support mAb in cocktails version against Sarscov-2 is also emerging, to support efficacy, as reported from some studies. Nice work sir. Wrm regards. Leo Ozurumba-Dwight